RedHill Biopharma (RDHL) EV to EBITDA (2014 - 2021)
RedHill Biopharma's EV to EBITDA was 2142.13 in the quarter ended Sep 30, 2021, down 65.8% from 6269.26 a year earlier and down 35.8% from the prior quarter.
Powered by 
Analysis
RedHill Biopharma (RDHL) EV to EBITDA (2014 - 2021) Analysis & Trends
On a trailing twelve-month basis, RedHill Biopharma's EV to EBITDA was 2139.88 through Sep 30, 2021, down 65.8% year-over-year; for the year ended Dec 31, 2020, it was 4743.98, down 1.6% from the prior year.
- In earlier years, EV to EBITDA was 4819.36 in the year ended Dec 31, 2019 (+48.1%), 3254.13 in the year ended Dec 31, 2018 (+86.8%), 1742.35 in the year ended Dec 31, 2017 (-60.3%) and 4393.10 in the year ended Dec 31, 2016 (-40.8%).
- The figure for the quarter ended Sep 30, 2021 marks the lowest quarterly EV to EBITDA since the quarter ended Mar 31, 2018.
- Compared with a year earlier, EV to EBITDA was higher in four of the last eight quarters, with growth averaging 5.3%.
- The best year-over-year quarter for EV to EBITDA over five years was the quarter ended Mar 31, 2019 (growth of 182.6%); the worst was the quarter ended Sep 30, 2021 (a decline of 65.8%).
- Per Business Quant data, RDHL's EV to EBITDA in the three quarters before the quarter ended Sep 30, 2021 was 3338.56 (quarter ended Jun 30, 2021), 4214.64 (quarter ended Mar 31, 2021) and 4725.19 (quarter ended Dec 31, 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | RedHill Biopharma | 1.44 Mn | -15.18 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 4.72 |
| Jun 30, 2021 | 7.24 |
| Mar 31, 2021 | 4.92 |
| Dec 31, 2020 | 6.91 |
| Sep 30, 2020 | 10.29 |
| Jun 30, 2020 | 7.73 |
| Mar 31, 2020 | 2.83 |
| Dec 31, 2019 | 9.52 |
| Sep 30, 2019 | 10.76 |
| Jun 30, 2019 | 10.25 |
| Mar 31, 2019 | 10.78 |
| Dec 31, 2018 | 6.33 |
| Sep 30, 2018 | 6.87 |
| Jun 30, 2018 | 6.09 |
| Mar 31, 2018 | 4.10 |
| Dec 31, 2017 | 3.72 |
| Sep 30, 2017 | 6.14 |
| Jun 30, 2017 | 6.79 |
| Mar 31, 2017 | 2.69 |
| Dec 31, 2016 | 2.23 |
API Access
RedHill Biopharma EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();